2014•Viral Hepatitis JournalOpen access

Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report

Tuğba Sarı, Süda Tekin Koruk, Fatih Temoçin

Abstract

1Buldan Chest Diseases Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Denizli, Turkey 2Harran University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sanliurfa, Turkey 3Yozgat Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Yozgat, Turkey Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/ Ribavirin+Telaprevir: A Case Report

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Telaprevir, Ribavirin, Pegylated interferon, Medicine, Hepatitis C, Virology, Internal medicine, Gastroenterology